Analysts Offer Predictions for ADCT FY2026 Earnings
ADC Therapeutics SA (NYSE:ADCT – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of ADC Therapeutics in a report released on Monday, June 9th. Cantor Fitzgerald analyst E. Schmidt expects that the company will post earnings per share of ($2.10) for the year. Cantor Fitzgerald […]
